314P Efficacy of taxane rechallenge in early metastatic relapse of HER2-negative breast cancer patients previously treated with taxane.

Saved in:
Bibliographic Details
Title: 314P Efficacy of taxane rechallenge in early metastatic relapse of HER2-negative breast cancer patients previously treated with taxane.
Authors: Vasseur, A.1 (AUTHOR), Carton, M.2 (AUTHOR), Guiu, S.3 (AUTHOR), Augereau, P.4 (AUTHOR), Uwer, L.5 (AUTHOR), Mouret Reynier, M.A.6 (AUTHOR), Levy, C.7 (AUTHOR), Eymard, J-C.8 (AUTHOR), Gonçalves, A.9 (AUTHOR), Robert, M.10 (AUTHOR), De La Motte Rouge, T.11 (AUTHOR), Bachelot, T.12 (AUTHOR), Petit, T.13 (AUTHOR), Debled, M.14 (AUTHOR), Grinda, T.15 (AUTHOR), Desmoulins, I.16 (AUTHOR), Vanlemmens, L.17 (AUTHOR), Dalenc, F.18 (AUTHOR), Simon, G.19 (AUTHOR), Cabel, L.20 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS501-S502. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2021.08.597